Category: Biotechnology
United States Biotechnology
-
Forensic Technologies and Services
... 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Forensic Services, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$29.6 Billion by the ... Read More
-
Tissue Engineering
... CAGR of 12.5% over the analysis period 2024-2030. Orthopedics, Musculoskeletal & Spine Application, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$12.7 Billion by the end ... Read More
-
Plant Cell Culture Equipment
... 2030, growing at a CAGR of 13.7% over the analysis period 2024-2030. Centrifuges, one of the segments analyzed in the report, is expected to record a 14.4% CAGR and reach US$784.8 Million by the end ... Read More
-
Exosome Research Products
... at a CAGR of 20.6% over the analysis period 2024-2030. Exosome Research Kits & Reagents, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$697.8 Million by ... Read More
-
Whole Exome Sequencing
... at a CAGR of 20.2% over the analysis period 2024-2030. Whole Exome Sequencing Systems, one of the segments analyzed in the report, is expected to record a 21.3% CAGR and reach US$4.1 Billion by the ... Read More
-
Pyrogen Testing
... CAGR of 10.4% over the analysis period 2024-2030. Pyrogen Testing Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 10.9% CAGR and reach US$1.1 Billion by the ... Read More
-
Genotyping
... 15.3% over the analysis period 2024-2030. Polymerase Chain Reaction (PCR) Technology, one of the segments analyzed in the report, is expected to record a 15.9% CAGR and reach US$10.9 Billion by the end of the ... Read More
-
COVID-19 Testing
... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More
-
Antisense and RNAi Therapeutics
... 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Antisense RNA Technology, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.8 Billion by ... Read More
-
USA Directory of Biotechnology Companies 2025
... is one of the most comprehensive & accurate Directory of companies & executives in the biotechnology industry that have ever been published. Hundreds of biotechnology companies & executives working in the industry throughout the USA. Read More
-
Biotechnology Market in US 2025-2029
... market in us provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
2025 North America Cancer Diagnostics Market in the USA, Canada, Mexico - 2024 Supplier Shares and Strategies by Country, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... LeadingMarketResearch.com provides information and analysis not available from any other published source , including 2024 supplier strategies and shares by country, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides ... Read More
-
2025 US Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
-
2025 Global Cancer Diagnostics Market in the USA, Europe, Japan - 2024 Supplier Shares and Strategies by Country, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... provides information and analysis not available from any other published source , including 2024 supplier strategies and shares by country, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a ... Read More
-
2025 United States Cancer Biomarkers Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Medical Device Mfg. industry. The global market is expected to increase from USD xx billion in 2026 to USD xx billion by 2031, at a CAGR of xx% from 2026 to 2031. Estimates on equipment ... Read More
-
2025 United States 3D Cell Culture Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... the Medical Device Mfg. industry. The global market is expected to increase from USD xx billion in 2026 to USD xx billion by 2031, at a CAGR of xx% from 2026 to 2031. Estimates on ... Read More
-
2025 United States Biologics Contract Development Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... the Medical Device Mfg. industry. The global market is expected to increase from USD xx billion in 2026 to USD xx billion by 2031, at a CAGR of xx% from 2026 to 2031. Estimates on ... Read More
-
2025 United States Antinuclear Antibody (Ana) Test Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... within the Medical Device Mfg. industry. The global market is expected to increase from USD xx billion in 2026 to USD xx billion by 2031, at a CAGR of xx% from 2026 to 2031. Estimates ... Read More
-
2025 United States Atomic Force Microscopy Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... the Semiconductor Mfg. industry. The global market is expected to increase from USD xx billion in 2026 to USD xx billion by 2031, at a CAGR of xx% from 2026 to 2031. Estimates on equipment ... Read More
-
2025 United States Assisted Reproductive Technology Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... the Medical Device Mfg. industry. The global market is expected to increase from USD xx billion in 2026 to USD xx billion by 2031, at a CAGR of xx% from 2026 to 2031. Estimates on ... Read More
-
2025 United States Cardiac Biomarkers Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Device Mfg. industry. The global market is expected to increase from USD xx billion in 2026 to USD xx billion by 2031, at a CAGR of xx% from 2026 to 2031. Estimates on equipment or ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Chemicals, Specialty Manufacturing, Including Fragrances, Silicones, Biodiesel & Enzymes (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325199
... Manufacturing, Including Fragrances, Silicones, Biodiesel & Enzymes (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325199 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325414
... and Biologicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325414 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. Key Findings: Vaccines, Skin Replacement ... Read More
-
US and Europe Pharma and Biotech Cro Market Research Report by Service Type (Clinical Development Services, Formulation Development Services, Pharmacovigilance Services, Laboratory Services, Consulting Services, Data Management Services, and Others), by Phase {Based on phase, the US and Europe Pharma and Biotech CRO Market has been segmented into Phase I, Phase II, Phase III, Phase IV. and Post Marketing Studies (PMS)}, by Indication 9 Based on Indication, the US and Europe Pharma and Biotech CRO Market has been segmented into cardiovascular, oncology, dermatology, gynecology, neurology, respiratory diseases, orthopedics, ophthalmology and others), by End User (Pharmaceutical Companies, and Biopharmaceutical Companies) Industry Forecast to 2032
... pharmaceutical and biotechnology industries by providing outsourced services such as drug development, clinical trials, regulatory affairs, and more. These include drug development, clinical trials, regulatory affairs, and post-market surveillance. CROs help streamline the drug development ... Read More
-
Biological Product (except Diagnostic) Manufacturing - 2025 U.S. Market Research Report with Updated Analysis & Forecasts
... of the industry in the United States with over 100 data sets covering 2016-2029. This 63-page Kentley Insights report is packed with insightful data sets and forecasts to give you a comprehensive understanding of the ... Read More